Company / Operating Income per Share
Seres Therapeutics, Inc. Operating Income per Share History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$22.55
FY2025
5-year range
-$22.55 / -$0.52
FY2021-FY2025
Trend
-4279.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share changed -4279% YoY in FY2025, a notable deviation from the 9-year average annual change of -493%.
Based on SEC 10-K filings.
-22.55 in FY2025.
Declined from $-0.96 to $-22.55 over the past 3 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share decreased 4279.2% year-over-year.
- Peak operating income per share was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.18 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$22.55 | -4279.2% |
| FY2023 | -$0.52 | +46.3% |
| FY2022 | -$0.96 | -22.0% |
| FY2021 | -$0.79 | +45.0% |
| FY2020 | -$1.43 | +36.0% |
| FY2019 | -$2.23 | +2.4% |
| FY2018 | -$2.29 | -68.3% |
| FY2017 | -$1.36 | -252.2% |
| FY2016 | -$0.39 | +56.1% |
| FY2015 | -$0.88 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 24, 2026